Search

ANI Pharmaceuticals Inc

Avatud

SektorTervishoid

74.98 1.7

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

73.05

Max

74.76

Põhinäitajad

By Trading Economics

Sissetulek

-655K

27M

Müük

29M

266M

P/E

Sektori keskmine

16.558

57.371

Aktsiakasum

1.82

Kasumimarginaal

10.064

Töötajad

970

EBITDA

3M

60M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+49.43% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

6. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-74M

1.7B

Eelmine avamishind

73.28

Eelmine sulgemishind

74.98

Uudiste sentiment

By Acuity

55%

45%

286 / 340 Pingereas Healthcare

ANI Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. aug 2026, 20:13 UTC

ANI Pharmaceuticals Inc. shares are higher in after-market trading, recovering from four consecutive sessions of losses amid ongoing geopolitical concerns.

21. aug 2026, 20:01 UTC

ANI Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close and trading near the lower end of its one-month range.

20. aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading lower today, having peaked earlier in the session. The stock remains below its 20-day moving average amid strong labor market data.

19. aug 2026, 23:41 UTC

ANI Pharmaceuticals Inc. shares declined after-market, falling sharply below the 20-day moving average and near the lower end of their one-month trading range.

18. aug 2026, 20:12 UTC

ANI Pharmaceuticals shares are higher in after-market trading, despite no specific news. The asset remains near the lower end of its one-month range.

17. aug 2026, 19:36 UTC

News

ANI Pharmaceuticals reports $266 million in Q2 revenue, exceeding estimates. However, shares are lower amid guidance concerns and broader market declines.

14. aug 2026, 19:26 UTC

ANI Pharmaceuticals is trading higher, recovering from an early drop amid broader market concerns following a decline in U.S. retail sales for July.

13. aug 2026, 22:16 UTC

ANI Pharmaceuticals Inc. shares showed routine trading activity in after-market hours, remaining roughly flat since Thursday's close and near the lower end of its one-month range.

12. aug 2026, 19:36 UTC

ANI Pharmaceuticals Inc shares are higher during Wednesday's session amid a broader market optimism following a modest increase in inflation data.

11. aug 2026, 19:56 UTC

News

ANI Pharmaceuticals shares are lower despite a 25.9% sales increase to $266 million. Full-year revenue guidance of $1.11 billion fell short of estimates.

10. aug 2026, 20:01 UTC

News

ANI Pharmaceuticals shares are lower today as analysts cut price targets, despite strong Q2 earnings that exceeded estimates and revenue growth.

7. aug 2026, 20:03 UTC

News

ANI Pharmaceuticals shares are lower after reporting Q2 revenue of $266 million and providing full-year guidance of $1.11 billion, below analyst estimates.

6. aug 2026, 19:51 UTC

News

ANI Pharmaceuticals shares are rising amid high trading volume ahead of its Q2 earnings report. Analysts expect revenue growth to decelerate compared to last year.

5. aug 2026, 20:06 UTC

ANI Pharmaceuticals Inc shares are higher today, though no specific news explains the move. Market sentiment has improved amid a decline in crude oil prices.

4. aug 2026, 19:33 UTC

News

ANI Pharmaceuticals is declining today despite noted revenue growth and improved cash flow margins, as sector regulation raises caution about earnings potential.

3. aug 2026, 19:46 UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

31. juuli 2026, 20:06 UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

30. juuli 2026, 20:09 UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

29. juuli 2026, 19:19 UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

28. juuli 2026, 20:02 UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

24. juuli 2026, 20:06 UTC

News

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

22. juuli 2026, 20:01 UTC

News

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

21. juuli 2026, 20:12 UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

20. juuli 2026, 19:46 UTC

News
Social Media

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.

Võrdlus sarnastega

Hinnamuutus

ANI Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

49.43% tõus

12 kuu keskmine prognoos

Keskmine 110.83 USD  49.43%

Kõrge 121 USD

Madal 90 USD

Põhineb 6 Wall Streeti analüütiku instrumendi ANI Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

5

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

286 / 340 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
help-icon Live chat